Quarterly EPS Estimate For CEPHEID (NASDAQ:CPHD) Cited At $-0.01


The average EPS estimate for CEPHEID (NASDAQ:CPHD) for the three months ending 2016-12-31 is given as $-0.01.

You find that 7 days ago, the average EPS estimate on the stock was $-0.01, while for the 30 days ago the average EPS estimate stood at $-0.01.

If you look back further, you see that the average EPS estimate for CEPHEID (NASDAQ:CPHD) 60 days ago was given as -0.01, while EPS estimate 90 days ago was quoted at $-0.01.

The change in the stock’s EPS estimate over the last 7 days works out to 0%.

EPS estimate revisions

Over the last 7 days, EPS estimates for CEPHEID (NASDAQ:CPHD) have been revised up 0 times. In the same period, the EPS estimate has been revised down 0 times.

In the last 30 days, the stock has had its EPS estimate revised up 1 and it has been revised up 1 times over the last 60 days.

Up revisions in the last 90 days are 1 and up revisions in the last 120 days are 2.

But for the last 18 days, the company has seen its EPS revised up 2 times, offset by 0 down revisions in the same period.

The down revisions of EPS in last 30, 60, 90 and 120 days were 0, 0, 0 and 0.

What About EPS Surprises

Analysts predicted EPS of $-0.01 for CEPHEID (NASDAQ:CPHD) for the period ended 2. But the company ended up posting actual EPS of $-0.09 on 2016-07-28. The EPS estimate cited was worked out based on 3 estimates that analysts had issued on the stock.

Therefore, CEPHEID (NASDAQ:CPHD) posted EPS surprise of $0.05 per share in dollar terms, which works out to 35.71%. The standard deviation of the actual EPS reported by the company and the average EPS estimate immediately before the earnings were released works out to $0.06.

Quarterly Sales Estimates

For the fiscal year 2017, the mean and median annual sales estimates for the company are given as $198.847 and $200.812. The estimates are based on the projections of 5 analysts.

So far, the highest annual sales estimate for CEPHEID (NASDAQ:CPHD) stands at$205.826. That compares with the lowest annual sales estimate of $187. Calculating the standard deviation of the extreme annual sales estimates leads you to 7.049%.

Annual sales estimate adjustments

In the last 7 days, 5 analysts have raised their annual sales estimates for the company. But over the same period, 5 analysts have trimmed their annual sales estimates.

With that, you find that the percentage change in mean annual sales estimate in the last 7 days works out to 0.069%.

Over the last one month, though, 5 analysts moved to raise their sales estimates for CEPHEID (NASDAQ:CPHD). That compares with 5 analysts who cut their sales estimate for the company in the same period. That leads you to -1.61% as the mean sales estimate change over the last one month.

If you look back further, you see that over the last three months, 5 analysts have moved raise their sales estimates CEPHEID (NASDAQ:CPHD). That offset by 5 analysts who in the same period lowered their sales estimates for the stock. That works out to percentage change in mean sales estimate of -1.83% over a period of three months.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 17 times, 1 visits today)